Early improved and late defective cognition is reflected by dendritic spines in Tau.P301L mice.

J Neurosci

Laboratory of Experimental Genetics and Transgenesis/Experimental Genetics Group, Department of Human Genetics, Katholieke Universiteit Leuven, Campus Gasthuisberg, B-3000 Leuven, Belgium.

Published: December 2011

Cognitive demise correlates with progressive brain tauopathy in dementing patients. Improved cognition of young Tau.P301L mice contrasts with dysfunction later in life and remains unexplained (Boekhoorn et al., 2006). To unravel early mechanisms, we composed a correlative time line of clinical symptoms, cognitive defects, and biochemical and pathological traits, including comprehensive analysis of dendritic spines in specified regions of the cortex and hippocampus of young and adult Tau.P301L mice. Remarkably, young Tau.P301L mice have not more, but more mature spines than wild-type mice, revealing the anatomical substrate for their improved cognition and LTP. Spine maturation remained high in the hippocampus of adult Tau.P301L mice. However, spines regressed in length paralleling impaired cognition and increased Tau phosphorylation (Terwel et al., 2005). Conversely, spine maturation was unaffected in adult Tau.4R mice, while spine density was increased and length reduced similar to Tau.P301L mice. To explain how protein Tau promoted spinogenesis, we analyzed hippocampal synaptosomes and dendritic spines for mouse and human Tau. While synaptosomes were positive for both mouse and human Tau, weak variable reaction in spines was observed only after fixation according to Bouin. Mouse Tau was absent from spines in wild-type mice, dissociating the pathological actions of Tau in transgenic mice by relocalization into dendrites and spines from the physiological actions of protein Tau in axons only. We conclude that mutant protein Tau modulates cognition and morphology of spines similarly and in both directions, with pathology later in life coinciding with increased phosphorylation and relocalization of Tau from axons to soma and processes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6634152PMC
http://dx.doi.org/10.1523/JNEUROSCI.4859-11.2011DOI Listing

Publication Analysis

Top Keywords

taup301l mice
24
dendritic spines
12
protein tau
12
mice
10
spines
9
tau
9
improved cognition
8
young taup301l
8
adult taup301l
8
spines wild-type
8

Similar Publications

Article Synopsis
  • Alzheimer's disease (AD) is characterized by cognitive decline and specific brain changes, necessitating the development of effective animal models to study it.
  • Current transgenic mouse models have limitations in capturing the full complexity of human AD pathology and their interactions.
  • The novel APP/PS1-TauP301L-Adeno mouse model enhances understanding of AD mechanisms by inducing significant pathological symptoms, revealing the exacerbating effect of severe reactive astrogliosis on amyloid-β plaques and neurofibrillary tangles.
View Article and Find Full Text PDF

SUMO2 rescues neuronal and glial cells from the toxicity of P301L Tau mutant.

Front Cell Neurosci

December 2024

Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Introduction: Abnormal intracellular accumulation of Tau aggregates is a hallmark of Alzheimer's disease (AD) and other Tauopathies, such as Frontotemporal dementia (FTD). Tau deposits primarily affect neurons, but evidence indicates that glial cells may also be affected and contribute distinctively to disease progression. Cells can respond to toxic insults by orchestrating global changes in posttranslational modifications of their proteome.

View Article and Find Full Text PDF
Article Synopsis
  • Neurofibrillary tangles (NFTs), linked to Alzheimer's disease (AD) neurodegeneration, consist of hyperphosphorylated tau proteins, particularly affecting memory in the hippocampus.* -
  • The study investigated the effects of AL04, a new protein treatment, on lowering hyperphosphorylated tau in a specific mouse model with human tau mutation, revealing significant decreases in tau levels and changes in autophagy-related proteins.* -
  • Findings suggest that AL04 could serve as a potential preventive and therapeutic agent for AD by promoting tau degradation and regulating relevant protein pathways.*
View Article and Find Full Text PDF
Article Synopsis
  • Tauopathy, including disorders like frontotemporal lobar dementia and Alzheimer's, involves the harmful buildup of Tau protein due to issues in protein management.
  • In a study using transgenic zebrafish, researchers found that Tau protein was effectively cleared through enhanced autophagy, but tauopathy-like symptoms appeared when autophagy was inhibited.
  • The study highlighted the crucial role of the protein valosin-containing protein (VCP) in promoting Tau degradation, with findings suggesting that boosting VCP could be a promising therapy for tauopathy, particularly in Alzheimer’s patients where VCP levels are significantly lower.
View Article and Find Full Text PDF

The NRF2 inducer CDDO-2P-Im provokes a reduction in amyloid β levels in Alzheimer's disease model mice.

J Biochem

November 2024

Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8573, Japan.

Alzheimer's disease (AD) is the most common aetiology of dementia. The transcription factor NF-E2-related factor 2 (NRF2) induces the expression of genes encoding phase II detoxification and antioxidant genes. NRF2 is regulated by Kelch-like ECH-associated protein 1 (KEAP1), and the KEAP1-NRF2 system is the key regulatory system involved in cytoprotection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!